Valuation Instituto Rosenbusch S.A.

Stocks

End-of-day quote Buenos Aires S.E. 2026-11-03			5-day change	1st Jan Change
140.00 ^ARS	+2.94%		+2.56%	-41.79%

09-15	Instituto Rosenbusch S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-06	Instituto Rosenbusch S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	489.8	468.5	549.4	2,726	5,196	10,243
Change	-	-4.35%	17.27%	396.12%	90.63%	97.13%
Enterprise Value (EV) ¹	597	602.5	787.7	3,369	6,059	10,981
Change	-	0.92%	30.75%	327.65%	79.86%	81.22%
P/E	-28.8x	-23.9x	-67.8x	4.84x	-3.67x	-2.23x
PBR	3.76x	2.65x	1.51x	1.42x	1.83x	-12.8x
PEG	-	-1.6x	1.2x	-0x	0x	-0x
Capitalization / Revenue	0.88x	0.6x	0.4x	0.6x	0.63x	1.6x
EV / Revenue	1.07x	0.77x	0.57x	0.74x	0.73x	1.71x
EV / EBITDA	7.27x	13.5x	2.48x	27.5x	2.98x	-3.46x
EV / EBIT	9.38x	28x	2.95x	213x	3.24x	-3.26x
EV / FCF	7.75x	-15.3x	5.1x	-3.01x	2.12x	6.74x
FCF Yield	12.9%	-6.52%	19.6%	-33.2%	47.2%	14.8%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.3993	-0.4595	-0.1901	13.22	-33.28	-108
Distribution rate	-	-	-	-	-	-
Net sales ¹	558.6	781.6	1,373	4,528	8,275	6,404
EBITDA ¹	82.12	44.7	317.2	122.7	2,031	-3,177
EBIT ¹	63.65	21.55	267.2	15.78	1,871	-3,369
Net income ¹	-17.01	-19.57	-8.098	562.9	-1,417	-4,598
Net Debt ¹	107.2	134	238.3	643.1	863.2	737.7
Reference price ²	11.50	11.00	12.90	64.00	122.00	240.50
Nbr of stocks (in thousands)	42,589	42,589	42,589	42,589	42,589	42,589
Announcement Date	4/5/21	3/13/22	3/20/23	3/27/24	4/7/25	4/9/26

¹ARS in Million²ARS

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
INSTITUTO ROSENBUSCH S.A.	-	-	-	-	3.86M
ELI LILLY AND COMPANY	41.24x	13.94x	30.97x	0.48%	1,255B
JOHNSON & JOHNSON	38.96x	6.55x	18.42x	2.01%	641B
ABBVIE INC.	36.79x	8.37x	17.26x	2.42%	505B
ROCHE HOLDING AG	21.08x	5.12x	12.75x	2.56%	381B
MERCK & CO., INC.	95.75x	5.88x	25.02x	2.35%	357B
NOVARTIS AG	22.88x	5.88x	14.19x	2.73%	303B
ASTRAZENECA PLC	24.26x	4.85x	13.68x	1.8%	286B
AMGEN INC.	29.25x	7.46x	13.36x	2.19%	249B
GILEAD SCIENCES, INC.	-40.09x	7.32x	45.96x	1.97%	208B
Average	30.01x	7.26x	21.29x	2.06%	418.52B
Weighted average by Cap.	35.93x	8.73x	22.53x	1.73%